Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs SBAC✓SelectedUSD · SBACMRNA vs SBAC performance historyLatest closeAs of-4.84%11/18
Stock and ETF performance explorer

MRNA vs SBAC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+958.0%
SBAC return
+12.1%
Excess return
+945.9%
Maximum drawdown
-95.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioSBACExcessAlpha
1D-4.8%-0.7%-4.2%-4.7%
7D-20.9%-8.1%-12.7%-18.9%
30D-13.3%-4.7%-8.6%-12.2%
3M+212.6%-3.1%+215.7%+214.9%
6M+309.0%-13.0%+322.1%+321.8%
YTD+567.3%-8.0%+575.3%+569.7%
1Y+689.7%-9.9%+699.6%+698.2%
3Y+157.4%-20.8%+178.3%+166.4%
5Y-21.7%-45.1%+23.4%-10.3%
All+958.0%+12.1%+945.9%+823.5%

Cumulative growth

Daily Returns

Daily percentage return beside SBAC.

Daily Out/Under-Performance

Portfolio return minus SBAC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling